Clinical Features and Novel Pathogenic Variants of Chinese Patients With McLeod Syndrome and Chorea‐Acanthocytosis
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.70015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Hao Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics and Center for Rare Diseases, Second Affiliated Hospital, Zhejiang University School of Medicine and Zhejiang Key Labo…. Hauptthemen laut MEDLINE: Amino Acid Transport Systems, Neutral, Neuroacanthocytosis, Vesicular Transport Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
McLeod syndrome (MLS) and chorea‐acanthocytosis (ChAc) are exceedingly rare diseases characterized by a variety of movement disorders including chorea, dystonia, and Parkinsonism. Genetic analysis plays a key role in early and accurate diagnosis, but relevant variants are still under investigation. This study aims to explore new pathogenic variants in Chinese patients with MLS and ChAc and to conduct a comprehensive analysis of the clinical heterogeneity among these patients.
Methods
Eighteen Chinese patients who presented with choreatic movements with negative HTT genetic testing were identified and underwent targeted next‐generation sequencing, verified by Sanger sequencing.
Results
Two novel XK variants (c.970A>T, c.422_423del) were identified in three index MLS patients and six novel VPS13A variants (c.9219C>A, c.3467T>A, c.4208dup, c.9243_9246del, c.5364del, c.556‐290_697‐483del) in five index ChAc patients. One copy number variant of VPS13A (g.79827595_79828762del/c.556‐290_697‐483del) was firstly described in Chinese population.
Conclusion
As the currently largest descriptive study of MLS and ChAc patients in China, this study expands on the clinical and genetic spectrum of XK and VPS13A , contributing to the clinical diagnosis of MLS and ChAc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics and Center for Rare Diseases, Second Affiliated Hospital, Zhejiang University School of Medicine and Zhejiang Key Laboratory of Rare Diseases for Precision Medicine and Clinical Translatio…
- Department of Neurology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.
- Research Centre for Intelligent Healthcare, Faculty of Health and Life Sciences, Coventry University, Coventry, UK.
ORCID-Profile: Haipeng Liu
Förderung
- The National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Yu, H., Li, L., Li, X., & Liu, H. (2024). Clinical Features and Novel Pathogenic Variants of Chinese Patients With McLeod Syndrome and Chorea‐Acanthocytosis. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70015
Vancouver
Yu H, Li L, Li X, Liu H. Clinical Features and Novel Pathogenic Variants of Chinese Patients With McLeod Syndrome and Chorea‐Acanthocytosis. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.70015
BibTeX
@article{Yu2024,
author = {Yu, Hao and Li, Ling and Li, Xiaoyan and Liu, Haipeng},
title = {Clinical Features and Novel Pathogenic Variants of Chinese Patients With McLeod Syndrome and Chorea‐Acanthocytosis},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.70015}
}
EUVIMED